A
Allan D. Sniderman
Researcher at McGill University Health Centre
Publications - 122
Citations - 7096
Allan D. Sniderman is an academic researcher from McGill University Health Centre. The author has contributed to research in topics: Apolipoprotein B & Cholesterol. The author has an hindex of 42, co-authored 122 publications receiving 6197 citations. Previous affiliations of Allan D. Sniderman include Université de Montréal.
Papers
More filters
Journal ArticleDOI
The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery.
Lucien Campeau,Marc Enjalbert,Jacques Lespérance,Martial G. Bourassa,Peter O. Kwiterovich,Sholom Wacholder,Allan D. Sniderman +6 more
TL;DR: The findings indicate that atherosclerosis in patients with saphenous-vein aortocoronary bypass surgery was a progressive disease, frequently affecting both the grafts and the native vessels, and that the course of such disease may be related to the plasma lipoprotein levels.
Journal ArticleDOI
A Meta-Analysis of Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, and Apolipoprotein B as Markers of Cardiovascular Risk
Allan D. Sniderman,Kenneth C. Williams,John H. Contois,Howard M. Monroe,Matthew J. McQueen,Jacqueline de Graaf,Curt D. Furberg +6 more
TL;DR: This meta-analysis based on all the published epidemiological studies that contained estimates of the relative risks of non-HDL-C and apoB of fatal or nonfatal ischemic cardiovascular events further validate the value of apo B in clinical care.
Journal ArticleDOI
Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment.
Allan D. Sniderman,C. D. Furberg,Anthony C Keech,J. E. Roeters Van Lennep,Jiri Frohlich,Ingmar Jungner,Göran Walldius,Göran Walldius +7 more
TL;DR: Results of many studies show that apolipoprotein B is a better marker of risk of vascular disease and a better guide to the adequacy of statin treatment than any cholesterol index.
Journal ArticleDOI
Hypertriglyceridemic HyperapoB: The Unappreciated Atherogenic Dyslipoproteinemia in Type 2 Diabetes Mellitus
TL;DR: Physicians should understand hypertriglyceridemic hyperapoB pathophysiology in order to better select and monitor therapy.
Journal ArticleDOI
Hyperlipidemia in Early Adulthood Increases Long-Term Risk of Coronary Heart Disease
Ann Marie Navar-Boggan,Eric D. Peterson,Ralph B. D'Agostino,Benjamin Neely,Allan D. Sniderman,Michael J. Pencina +5 more
TL;DR: Cumulative exposure to hyperlipidemia in young adulthood increases the subsequent risk of CHD in a dose-dependent fashion and adults with prolonged exposure to even moderate elevations in non–high-density lipoprotein cholesterol have elevated risk for future CHD and may benefit from more aggressive primary prevention.